Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived Stem Cells for Knee Osteoarthritis
NCT03308006Phase 2Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adipose derived mesenchymal stromal cells in osteoarthritis (OA), sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: Regenerated cartilage at 1 year. Started Jan 2018; status: completed.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03308006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03308006.